Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia

被引：22
|
作者：
Ferrari, Marco [2 ]
Bolla, Emilio [1 ]
Bortolaso, Paola [1 ]
Callegari, Camilla [1 ]
Poloni, Nicola [1 ]
Lecchini, Sergio [2 ]
Vender, Simone [1 ]
Marino, Franca [2 ]
Cosentino, Marco [2 ]
机构：
[1] Univ Insubria, Dept Clin Med, Sect Psychiat, I-21100 Varese, Italy
[2] Univ Insubria, Dept Clin Med, Sect Clin & Expt Pharmacol, I-21100 Varese, Italy
来源：
PSYCHIATRY RESEARCH | 2012年 / 200卷 / 2-3期
关键词：
Pharmacogenetic; Schizophrenia; Cytochrome; GENETIC-POLYMORPHISM; RESISTANCE;
D O I：
10.1016/j.psychres.2012.07.002
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
We investigated the relationships between common polymorphisms in CYP1A2 (CYP1A2*1C and *1F), CYP1A2-mRNA levels in circulating lymphocytes and clozapine(CLZ)-induced adverse drug reactions (ADRs) in 34 patients. Patients with ADRs had a higher frequency of CYP1A2 low activity allele combinations (8/12; 67%) and lower CYP1A2-mRNA levels than patients without ADRs (6/22; 27%, P=0.019). (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：1014 / 1017
页数：4
相关论文
共 50 条
  • [21] Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis
    Ortega-Vazquez, Alberto
    Mayen-Lobo, Yerye G.
    Davila-Ortiz de Montellano, David J.
    Tristan-Lopez, Luis
    Avina-Cervantes, Carlos L.
    Rios, Camilo
    Lopez-Lopez, Marisol
    Monroy-Jaramillo, Nancy
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (05) : 685 - 694
  • [22] CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients
    van Troostwijk, LJAED
    Koopmans, RP
    Vermeulen, HDB
    Guchelaar, HJ
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 20 (4-5) : 451 - 457
  • [23] Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma
    Prawan, A
    Kukongviriyapan, V
    Tassaneeyakul, W
    Pairojkul, C
    Bhudhisawasdi, V
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (03) : 245 - 250
  • [24] Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma
    Obase, Y
    Shimoda, T
    Kawano, T
    Saeki, S
    Tomari, S
    Mitsuta-Izaki, K
    Matsuse, H
    Kinoshita, M
    Kohno, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (05) : 468 - 474
  • [25] The CYP1A2-163C > A polymorphism is associated with clozapine-induced generalized tonic-clonic seizures in Brazilian schizophrenia patients
    Kohlrausch, Fabiana Barzotti
    Severino-Gama, Clarissa
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo
    Carracedo, Angel
    Hutz, Mara Helena
    PSYCHIATRY RESEARCH, 2013, 209 (02) : 242 - 245
  • [26] CYP1A1/CYP1A2 polymorphisms and colorectal cancer
    Ozhan, Gul
    Mutur, Mine
    TOXICOLOGY LETTERS, 2012, 211 : S69 - S69
  • [27] Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia
    Kang, Shi Hyun
    Lee, Jong-il
    Han, Hye Ree
    Soh, Minah
    Hong, Jin Pyo
    PSYCHIATRIC GENETICS, 2014, 24 (06) : 249 - 256
  • [28] Smoking impact on CYP1A2 activity in a group of patients with schizophrenia
    Bozikas, VP
    Papakosta, M
    Niopas, L
    Karavatos, A
    Mirtsou-Fidani, V
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (01) : 39 - 44
  • [29] Clozapine pharmacokinetics studied with CYP1A2 knockout mice
    Aitchison, KJ
    Jann, MW
    Wolff, K
    Sakai, T
    Makoff, AJ
    Collier, DA
    Gonzalez, FJ
    Kerwin, RW
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 235 - 235
  • [30] The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine
    Eiermann, B
    Engel, G
    Johansson, I
    Zanger, UM
    Bertilsson, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) : 439 - 446
12345